130 related articles for article (PubMed ID: 3900362)
1. A double-blind trial of phenelzine in bulimia.
Walsh BT; Stewart JW; Roose SP; Gladis M; Glassman AH
J Psychiatr Res; 1985; 19(2-3):485-9. PubMed ID: 3900362
[TBL] [Abstract][Full Text] [Related]
2. Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study.
Walsh BT; Stewart JW; Roose SP; Gladis M; Glassman AH
Arch Gen Psychiatry; 1984 Nov; 41(11):1105-9. PubMed ID: 6388524
[TBL] [Abstract][Full Text] [Related]
3. Phenelzine vs placebo in 50 patients with bulimia.
Walsh BT; Gladis M; Roose SP; Stewart JW; Stetner F; Glassman AH
Arch Gen Psychiatry; 1988 May; 45(5):471-5. PubMed ID: 3282482
[TBL] [Abstract][Full Text] [Related]
4. Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin.
Sabine EJ; Yonace A; Farrington AJ; Barratt KH; Wakeling A
Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):195S-202S. PubMed ID: 6337607
[No Abstract] [Full Text] [Related]
5. An open trial of MAO inhibitors in bulimia.
Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH
J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746
[TBL] [Abstract][Full Text] [Related]
6. Bulimia treated with imipramine: a placebo-controlled, double-blind study.
Pope HG; Hudson JI; Jonas JM; Yurgelun-Todd D
Am J Psychiatry; 1983 May; 140(5):554-8. PubMed ID: 6342421
[TBL] [Abstract][Full Text] [Related]
7. Treating bulimia with desipramine. A double-blind, placebo-controlled study.
Hughes PL; Wells LA; Cunningham CJ; Ilstrup DM
Arch Gen Psychiatry; 1986 Feb; 43(2):182-6. PubMed ID: 3511878
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled studies of bulimic patients.
Rosebush P
Am J Psychiatry; 1986 Sep; 143(9):1197-8. PubMed ID: 3529997
[No Abstract] [Full Text] [Related]
9. Bulimia and monoamine oxidase inhibitors: a predictor study.
Hardy BW; Waller DA; Orsulak PJ
Tex Med; 1985 Oct; 81(10):39-42. PubMed ID: 3904070
[No Abstract] [Full Text] [Related]
10. A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.
Rothschild R; Quitkin HM; Quitkin FM; Stewart JW; Ocepek-Welikson K; McGrath PJ; Tricamo E
Int J Eat Disord; 1994 Jan; 15(1):1-9. PubMed ID: 8124322
[TBL] [Abstract][Full Text] [Related]
11. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
[TBL] [Abstract][Full Text] [Related]
12. Suppression of bulimic symptoms with methylamphetamine.
Ong YL; Checkley SA; Russell GF
Br J Psychiatry; 1983 Sep; 143():288-93. PubMed ID: 6354341
[TBL] [Abstract][Full Text] [Related]
13. Use of L-tryptophan in treating bulimia.
Krahn D; Mitchell J
Am J Psychiatry; 1985 Sep; 142(9):1130. PubMed ID: 3895989
[No Abstract] [Full Text] [Related]
14. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.
Georgotas A; McCue RE; Cooper TB
Arch Gen Psychiatry; 1989 Sep; 46(9):783-6. PubMed ID: 2673129
[TBL] [Abstract][Full Text] [Related]
15. How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine.
Rabkin JG; Markowitz JS; Stewart J; McGrath P; Harrison W; Quitkin FM; Klein DF
Psychiatry Res; 1986 Sep; 19(1):75-86. PubMed ID: 3538107
[TBL] [Abstract][Full Text] [Related]
16. Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity.
Stewart JW; Harrison W; Cooper TB; Quitkin FM
Psychiatry Res; 1988 Aug; 25(2):195-201. PubMed ID: 3051071
[TBL] [Abstract][Full Text] [Related]
17. Treatment of bulimia with lithium.
Hsu LK
Am J Psychiatry; 1984 Oct; 141(10):1260-2. PubMed ID: 6435459
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine in the treatment of bulimia.
Kaplan AS; Garfinkel PE; Darby PL; Garner DM
Am J Psychiatry; 1983 Sep; 140(9):1225-6. PubMed ID: 6577802
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
[TBL] [Abstract][Full Text] [Related]
20. A comparison of phenelzine and imipramine in depressed inpatients.
Davidson JR; McLeod MN; Turnbull CD; Miller RD
J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
